Erytropoietin behandling kan forbedre kognition ved neuropsykiatriske lidelser

TY - JOUR

T1 - Erytropoietin behandling kan forbedre kognition ved neuropsykiatriske lidelser

AU - Kjær, Kristian Skov

AU - Hageman, Ida

AU - Wörtwein, Gitta

AU - Jørgensen, Martin Balslev

AU - Miskowiak, Kamilla Woznica

PY - 2017/8/14

Y1 - 2017/8/14

N2 - Cognitive dysfunction is a core feature in a range of neuropsychiatric disorders which reduces patients' workforce capacity - the largest socio-economic cost of these disorders. Nevertheless, there is no clinically available medical treatment with robust and enduring efficacy on cognitive deficits in most neuropsychiatric conditions. Recent research has shown that erythropoietin may have beneficial effects on cognitive dysfunction across neuropsychiatric disorders, including bipolar and unipolar disorders, schizophrenia, Parkinson's disease and multiple sclerosis.

AB - Cognitive dysfunction is a core feature in a range of neuropsychiatric disorders which reduces patients' workforce capacity - the largest socio-economic cost of these disorders. Nevertheless, there is no clinically available medical treatment with robust and enduring efficacy on cognitive deficits in most neuropsychiatric conditions. Recent research has shown that erythropoietin may have beneficial effects on cognitive dysfunction across neuropsychiatric disorders, including bipolar and unipolar disorders, schizophrenia, Parkinson's disease and multiple sclerosis.

KW - English Abstract

KW - Journal Article

M3 - Tidsskriftartikel

C2 - 28869012

SN - 0041-5782

VL - 179

SP - 2

EP - 6

JO - Ugeskrift for Laeger

JF - Ugeskrift for Laeger

IS - 22

M1 - V01170037

ER -